Abbott Labs spin-off AbbVie (ABBV) forecasts 2013 earnings in line with consensus, predicting...

|About: AbbVie Inc. (ABBV)|By:, SA News Editor

Abbott Labs spin-off AbbVie (ABBV) forecasts 2013 earnings in line with consensus, predicting adjusted EPS of $3.03-$3.13 vs estimates of $3.08. AbbVie expects its growth to be driven by new treatments for illnesses that have a high unmet need.